To determine whether B7-H3 can also be used as a target antigen in human GBM, we first analyzed the gene expression profiles of glioma samples in The Cancer Genome Atlas (TCGA) [54–56] and Chinese Glioma Genome Atlas (CGGA) databases [57]. This evidence concerns the gene CD276 and glioblastoma.